vorinostat has been researched along with Cancer-Associated Pain in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, XT | 1 |
| Hu, XF | 1 |
| Zhu, C | 1 |
| Zhou, KX | 1 |
| Zhao, WJ | 1 |
| Zhang, C | 1 |
| Han, X | 1 |
| Wu, CL | 1 |
| Wei, YY | 1 |
| Wang, W | 1 |
| Deng, JP | 1 |
| Chen, FM | 1 |
| Gu, ZX | 1 |
| Dong, YL | 1 |
1 other study available for vorinostat and Cancer-Associated Pain
| Article | Year |
|---|---|
Suppression of histone deacetylases by SAHA relieves bone cancer pain in rats via inhibiting activation of glial cells in spinal dorsal horn and dorsal root ganglia.
Topics: Analgesics; Animals; Bone Neoplasms; Cancer Pain; Female; Ganglia, Spinal; Histone Deacetylase Inhib | 2020 |